Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 15121–15140 of 17,529 recalls

September 17, 2013· Lupin Pharmaceuticals Inc.

Recalled Item: Quinapril Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 17, 2013· Amgen, Inc.

Recalled Item: Prolia (denosumab) Injection

The Issue: Presence of Particulate Matter: Visible cellulose fibers were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 17, 2013· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Amlodipine Besylate Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 17, 2013· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Amlodipine Besylate Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 17, 2013· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Amlodipine Besylate Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 16, 2013· Hospira, Inc.

Recalled Item: 1% Lidocaine HCl Injection

The Issue: Presence of Particulate Matter: Oxidized stainless steel found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
September 16, 2013· Kremers Urban Pharmaceuticals, Inc.

Recalled Item: Omeprazole Delayed-Release Capsules

The Issue: Failed Tablet/Capsule Specification: some capsules over time do

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 16, 2013· Osmotica Pharmaceutical Corp

Recalled Item: Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets

The Issue: Failed Dissolution Specification:12 hour time point at 18

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 16, 2013· Hospira, Inc.

Recalled Item: Morphine Sulfate Injection

The Issue: Lack of Assurance of Sterility: Confirmed customer report

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Lamotrigine Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate and Benazepril HCl Capsules

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· AmeriSource Bergen

Recalled Item: Ifosfamide Injection 1g/20mL

The Issue: Temperature abuse: Certain vials of Ifosfamide IV products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· AmeriSource Bergen

Recalled Item: Ifosfamide Injection 3g/60 mL

The Issue: Temperature abuse: Certain vials of Ifosfamide IV products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate and Benazepril HCl Capsules

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate and Benazepril HCl Capsules

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Ciprofloxacin Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate and Benazepril HCl Capsules

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate and Benazepril HCl Capsules

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 13, 2013· Mylan Pharmaceuticals Inc.

Recalled Item: Amlodipine Besylate Tablets

The Issue: CGMP Deviations: Pharmaceuticals were produced and distributed with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund